Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Genetic Disorder: early-phase trial registry

1 of 6 indexed Genetic Disorder trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 1 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Genetic Disorder: 6 US clinical trials tracked, 1 recruiting.

Genetic Disorder is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), running 2 of these trials.

Enrollment posture brief

Registry condition genetic-disorder

OPEN 1 | RECR 17% | LATE 0 | EARLY 1 | RANK #2866 | SPON 2

Nearest open-share peer: Acute Renal Failure (17% recruiting · 6 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Genetic Disorder (this)17%
Open-enrollment share among volume-matched conditions near Genetic Disorder

Genetic Disorder lists 1 open slots (17% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Genetic Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Genetic Disorder is recruiting below its size-band peers.

    1 of 6 indexed trials (16.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Genetic Disorder research.

    Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Most Genetic Disorder trials plan to enrol fewer than 100 people.

    Median target enrolment is 96 among the 6 trials that report a genuine target (sentinel values excluded). 4 of those (66.7%) plan for fewer than 100 participants.

  4. Genetic Disorder research leans observational.

    2 interventional and 4 observational studies make up this index (33.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on Genetic Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

somatropin Drug
1 trials
Genetic Counseling Other
1 trials
Diagnostic Laboratory Biomarker Analysis Other
1 trials
Electronic Health Record Review Other
1 trials
Questionnaire Administration Other
1 trials
Biospecimen Collection Procedure
1 trials

US sites by state

Facility locations filed on Genetic Disorder trials. A trial with sites in several states counts in each.

Maryland 3 trials
Texas 1 trials
North Carolina 1 trials
Minnesota 1 trials
Indiana 1 trials
Florida 1 trials
Arizona 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Genetic Disorder page

6 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Genetic Disorder condition card totals 6 registered trials; most-linked intervention somatropin; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.